NVIDIA BioNeMo's NV-deCYPher takes 3rd on both OpenADMET Blind Challenge tracks
AllThingsApx · x · 2026-11-14
NVIDIA's BioNeMo team placed 3rd on both tracks of the OpenADMET Blind Challenge predicting CYP inhibition: Tier 1 on time-dependent inhibition and Tier 2 on direct inhibition. CYP inhibition causes drug-drug interactions often found late in development; early prediction helps teams design around the liability.
More from Apps
- shadcn UI SDK lets agents edit forms through the same components as humans — shadcn · 2026-11-14
- Google Flow's Omni 1.2 Flash Makes a Full 15-Second Beverage Ad from One Prompt — Emergency_Abies_6508 · 2026-11-14
- Anthropic launches Claude Meetings to bring meeting notes into Claude — hmokiguess · 2026-11-14
- Stranded at SFO, traveler has AI agent build an app that caught the first nationwide takeoff — patricksrail · 2026-11-14
- Infinitty overhaul: voice-driven Mac AI terminal with 20-agent multiplayer editing — jasonkneen · 2026-11-14
- YC F26 startup Anywhere launches a map app that lets AI agents read and edit your places — ycombinator · 2026-11-14